Mackenzie Financial
TSHA icon

Mackenzie Financial’s Taysha Gene Therapies TSHA Stock Holding History

Mackenzie Financial’s Portfolio TSHA Stock Details TSHA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-13,308
Closed -$75.2K – 1754
2025
Q4 		$75.2K Buy
13,308
+2,094
+19% +$10.2K ﹤0.01% 1609
2025
Q3 		$36.7K Hold
11,214
– – ﹤0.01% 1667
2025
Q2 		$25.9K Buy
11,214
+1,214
+12% +$2.64K ﹤0.01% 1669
2025
Q1 		$13.9K Hold
10,000
– – ﹤0.01% 1657
2024
Q4 		$17.3K Hold
10,000
– – ﹤0.01% 1686
2024
Q3 		$20.1K Buy
+10,000
New +$21.9K ﹤0.01% 1564

Other funds holding TSHA

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM